Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Klothonova
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Avant and Austrianova Sign Joint Venture, Agreement to Advance Klotho-Based Therapies
Details : Klothonova will leverage Austrianova's cellencapsulation technology to develop and commercialize treatments targeting Alzheimer's, cancer, kidney, heart and other age-related conditions.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
September 18, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Klothonova
Deal Size : Undisclosed
Deal Type : Licensing Agreement